A prospective real-world study evaluated Cardio-HART against echocardiography for LVEF estimation and heart failure classification, while highlighting the gap between the availability of echocardiography and timely cardiac assessment.
Beyond Agreement: A Real-World Study of Cardio-HART and Timely Structural Cardiac Assessment Read more »
Cardio-Phoenix is proposing a real-world evaluation (RWE) of Cardio-HART, a cardiac diagnostic system, under the NIHR funding competition i4i Challenge.
Cardio-Phoenix is applying for Real-World Evaluation of Cardio-HART for Diagnosis of Cardiovascular Conditions under NIHR i4i Challenge Funding Read more »
Using an AI solution to process ECG and novel bio-signals, the CHART algorithms are able to predict structural, functional, and valve abnormalities, effectively reducing this diagnostic gap, thereby allowing for the early detection of most common heart diseases and HF in primary care.
Detecting heart failure using novel bio-signals and a knowledge enhanced neural network Read more »
Cardiovascular Disease (CVD) was flagged by the NHS as the most prominent condition in which lives could be saved – with plans of preventing 150,000 heart attacks over a decade. What does the technology look like which can achieve this?
A tech approach to a long-term cardiovascular care Read more »
Background Clinical decisions about Heart Failure (HF) are frequently based on measurements of left ventricular ejection fraction (LVEF), relying mainly on echocardiography measurements for evaluating structural and functional abnormalities of heart disease.
Detecting Heart Failure using novel bio-signals and a Knowledge Enhanced Neural Network Read more »
Background Echocardiography (ECHO) is not widely available in primary care, the key structural (chamber enlargements) and functional abnormality are not easily available precluding the ability to diagnose HF other than through mainly symptomatic means. The opportunity for earlier detection of HF is lost.
Unraveling diagnostic co-morbidity makeup of each HF category as characteristically derived by ECG- and ECHO-findings Read more »
Cardio-HART is the clinician’s AI-powered heart diagnostic assistant. Early detection of heart disease can prolong or increase a patient's quality of life. In addition, it will reduce the burden on the health system and create better communication between GPs and cardiologists.
Novel tech throws knock-out punch to ECG improving GP referral decisions to cardiology Read more »
Cardio-Phoenix recently announced that it received CE Mark approval for its Cardio-Heart heart disease diagnostic device.
Cardio-Phoenix secures CE Mark for AI-powered heart diagnostic Read more »
CE-marked approval could change the work of specialists and allow them, at the end of the pandemic, to manage the wave of new heart patients.
Telemedicina cardiaca, arriva il dispositivo CHART che rileva il 95% di tutte le malattie del cuore Read more »
The great challenge to SARS-CoV-2 virus infection is played out on the ground, through the early identification of new infections and the identification of those at greater risk, such as people with confirmed cardiovascular diseases or risk factors, such as hypertension or obesity.
